Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.
作者信息
BARON J H, CONNELL A M, KANAGHINIS T G, LENNARD-JONES J E, JONES A F
出版信息
Br Med J. 1962 Aug 18;2(5302):441-3. doi: 10.1136/bmj.2.5302.441.
Abstract
摘要
相似文献
1
Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.溃疡性结肠炎的门诊治疗。三种剂量口服泼尼松的比较。
Br Med J. 1962 Aug 18;2(5302):441-3. doi: 10.1136/bmj.2.5302.441.
2
An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis.对泼尼松、柳氮磺胺吡啶和局部用半琥珀酸氢化可的松作为溃疡性结肠炎门诊治疗药物的评估。
Gut. 1960 Sep;1(3):217-22. doi: 10.1136/gut.1.3.217.
3
A comparative trial of salazopyrin, prednisone and hydrocortisone retention enemata in the out-patient treatment of left-sided colitis. Preliminary report.柳氮磺胺吡啶、泼尼松和氢化可的松保留灌肠剂门诊治疗左侧结肠炎的比较试验。初步报告。
Proc R Soc Med. 1960 Aug;53(8):647-50. doi: 10.1177/003591576005300817.
4
Experience with short and long term courses of local adrenal steroid therapy for ulcerative colitis. Report of 98 cases.溃疡性结肠炎局部肾上腺皮质类固醇短期和长期治疗经验。98例报告。
Gastroenterology. 1962 Jun;42:669-77.
5
Withdrawal of adrenal steroids and corticotropin. Clinical observations in chronic ulcerative colitis.肾上腺皮质类固醇和促肾上腺皮质激素的撤药。慢性溃疡性结肠炎的临床观察。
Arch Intern Med. 1961 Jan;107:88-94. doi: 10.1001/archinte.1961.03620010092015.
6
[Observations on 2 cases of ''ulcerative colitis'' treated with prednisone].[关于2例用泼尼松治疗的“溃疡性结肠炎”的观察]
Rev Fac Med Univ Nac Colomb. 1960 Apr-Jun;28:37-41.
7
Multiple ulcerations and perforations of the jejunum and ileum complicating prednisone therapy.空肠和回肠多发溃疡及穿孔，为泼尼松治疗的并发症。
AMA Arch Intern Med. 1957 Apr;99(4):660-8. doi: 10.1001/archinte.1957.00260040160016.
8
The longterm treatment of ulcerative colitis with hydrocortisone, prednisone and prednisolone.氢化可的松、泼尼松和泼尼松龙对溃疡性结肠炎的长期治疗。
Gastroenterology. 1957 Sep;33(3):423-33.
9
[Ambulatory treatment of patients with ulcerative colitis].[溃疡性结肠炎患者的门诊治疗]
Sov Med. 1989(11):89-92.
10
[Ambulatory treatment of ulcerative colitis].[溃疡性结肠炎的门诊治疗]
Dtsch Gesundheitsw. 1972 Sep 1;27(36):1717-9.
引用本文的文献
1
Common Mistakes in Managing Patients with Inflammatory Bowel Disease.炎症性肠病患者管理中的常见误区
J Clin Med. 2024 Aug 14;13(16):4795. doi: 10.3390/jcm13164795.
2
Post-hospitalization Short Versus Long Steroid Taper Strategies in Patients With Acute Severe Ulcerative Colitis: A Comparison of Clinical Outcomes.急性重症溃疡性结肠炎患者出院后短期与长期激素减量策略：临床结局比较
Crohns Colitis 360. 2024 Apr 27;6(2):otae025. doi: 10.1093/crocol/otae025. eCollection 2024 Apr.
3
A review of the therapeutic management of ulcerative colitis.溃疡性结肠炎的治疗管理综述。
Therap Adv Gastroenterol. 2022 Nov 29;15:17562848221138160. doi: 10.1177/17562848221138160. eCollection 2022.
4
Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice.临床实践中溃疡性结肠炎糖皮质激素初始剂量及减量率分析
JGH Open. 2022 Aug 20;6(9):612-620. doi: 10.1002/jgh3.12796. eCollection 2022 Sep.
5
Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α.炎症性肠病的常规治疗方法更新：5-氨基水杨酸、皮质类固醇、免疫调节剂和抗 TNF-α。
Korean J Intern Med. 2022 Sep;37(5):895-905. doi: 10.3904/kjim.2022.132. Epub 2022 Jul 27.
6
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.真实世界疗效和安全性监测预测溃疡性结肠炎患者托法替布治疗的持续。
Dig Dis Sci. 2022 Aug;67(8):3984-3992. doi: 10.1007/s10620-021-07233-6. Epub 2021 Aug 30.
7
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.英国胃肠病学会成人炎症性肠病管理共识指南。
Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27.
8
Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease.优化当前治疗方法的使用并采用新兴治疗方法，以实现炎症性肠病患者的治疗成功。
Gut Liver. 2020 Jan 15;14(1):7-19. doi: 10.5009/gnl18203.
9
Evidence-based clinical practice guidelines for inflammatory bowel disease.炎症性肠病的循证临床实践指南。
J Gastroenterol. 2018 Mar;53(3):305-353. doi: 10.1007/s00535-018-1439-1. Epub 2018 Feb 10.
10
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?炎症性肠病治疗的临床应答和缓解时间：临床医生应该期待什么，应该告诉患者什么？
World J Gastroenterol. 2017 Sep 21;23(35):6385-6402. doi: 10.3748/wjg.v23.i35.6385.
本文引用的文献
1
Systemic and local corticosteroid therapy in ulcerative colitis.溃疡性结肠炎的全身和局部皮质类固醇治疗。
Br Med J. 1960 Feb 13;1(5171):464-7. doi: 10.1136/bmj.1.5171.464.
2
An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis.对泼尼松、柳氮磺胺吡啶和局部用半琥珀酸氢化可的松作为溃疡性结肠炎门诊治疗药物的评估。
Gut. 1960 Sep;1(3):217-22. doi: 10.1136/gut.1.3.217.
Zotero 插件